Ovarian Cancer

ESGO eAcademy, Kim Jae-weon Kim, 403695

Benefit Of Peritoneal Staging In Clinical Early-Stage Mucinous Ovarian Carcinoma: A Dutch Population-Based Cohort Study Comparing The Expansile And Infiltrative Subtypes

ESGO eAcademy, Marc Algera, 403698

Unraveling The Transcriptomic Landscape Of Small Cell Carcinoma Of The Uterine Cervix: Insights Into Subtypes And Diagnostic Challenges

ESGO eAcademy, Vincent Cockenpot, 403697

Cervical Cancer

ESGO eAcademy, Nicoletta Colombo, 403694

ESGO 2023 Live Surgery

ESGO eAcademy, Faculty / Presenter(s), 402812

Updated Cervical Cancer Mobile App

ESGO eAcademy, Richard Schwameis, 403690

Fertility Sparing Treatment

ESGO eAcademy, Christhardt Koehler, 403689

Future Studies and Research Directions

ESGO eAcademy, Charalampos Theofanakis, 403686

Challenges in the Management of IB2/IB3 Tumours

ESGO eAcademy, David Cibula, 403688

Pre-, Pro-Biotics and Other Agents: Are They of Value?

ESGO eAcademy, Murat Gultekin, 403685

Laparoscopic Surgery - Extraperitoneal Aortic Dissection from IUCT Toulouse

ESGO eAcademy, Gwenael Ferron, 403691

Robotic Surgery - Radical Hysterectomy from Gemelli Rome

ESGO eAcademy, Francesco Fanfani, 403693

Treatment of Early Stages up to 2 cm

ESGO eAcademy, Marie Plante, 403687

Microbiome in Gynaecological Cancers: What Do We Really Know?

ESGO eAcademy, Maria Kyrgiou, 403684

Is Radical Hysterectomy Doomed to Disappear?

ESGO eAcademy, David Cibula, 403676

Interpreting Outcome Data from PARP Inhibitor Studies and Their Clinical Impact

ESGO eAcademy, Jonathan Ledermann, 403673

Case Discussion: Management and Prognosis of Abdominal/Thoracic Wall Metastasis

ESGO eAcademy, Glauco Baiocchi, 403678

CA125 Kinetics - KELIM to Help Select Patients for Bevacizumab, and Potentially PARPi, Treatment

ESGO eAcademy, Benoit You, 403672

Case Discussion: Management and Prognosis of Extra-Abdominal Lymph Nodes Metastasis

ESGO eAcademy, Beyhan Ataseven, 403677

Anatomical Landmarks of the QM Classification

ESGO eAcademy, Denis Querleu, 403674

Challenges of Implementing PARPi in Resource-Restricted Settings

ESGO eAcademy, Angelica Rodrigues, 403671

Laparoscopic Assisted Infralevator Posterior Exenteration With Vulvovaginal Reconstruction

ESGO eAcademy, Shylasree TS, 403667

Segmental Resection Of The Bowel In Multifocal Deep Infiltrative Endometriosis With The Ghost Ileostomy Due To Uncertain Vascularity Of The Bowel In The ICG Test – Presentation Of The Technique.

ESGO eAcademy, EWA MILNEROWICZ-NABZDYK, 403666

How Could We Improve Patients’ Sexual Health after the Treatment? Insights from the ENYGO-ENGAGe Survey

ESGO eAcademy, Zoia Razumova, 403670

Near-Infrared FluORescencE Assessment Of Myocutnaeous Flap Microperfusion For Gynecologic RecONstrucTion (FOREFRONT): A Prospective, Non-Randomized Trial (NCT05071976)

ESGO eAcademy, Beryl Manning-Geist, 403665

Mental Health as a Crucial Aspect in Quality of Life. How to Support Your Patient?

ESGO eAcademy, Annette Hasenburg, 403669

Oncovascular Surgery In Gynecologic Oncology: En Bloc Metastatic Lymph Node And Infiltrated Inferior Vena Cava Resection Followed By Patch Reconstruction

ESGO eAcademy, Giuseppe Cucinella, 403664

A Guide to Inform the Patient about the Quality of Life During Cancer Treatment

ESGO eAcademy, Vesna I. Kesic, 403668

Will the Primary Surgical Approach in Advanced Ovarian Cancer Be Guided by HRD Status? CON Opinion

ESGO eAcademy, Elena Ioanna Braicu, 403661

Will the Primary Surgical Approach in Advanced Ovarian Cancer Be Guided by HRD Status? PRO Opinion

ESGO eAcademy, Sudha Sundar, 403662

Surgical Planification Of 3D Reconstruction With Robotic Partial Cystectomy And Colpectomy For Cervical Cancer Recurrence.

ESGO eAcademy, Sergi Fernandez, 403663

Rare Tumours Algorithms in Mobile App: Small Cell Neuroendocrine Carcinoma of the Cervix

ESGO eAcademy, Richard Schwameis, 403654

DB-1303, A HER2-Targeting ADC, For Patients With Advanced/Metastatic Endometrial Cancer: Preliminary Clinical Results From An Ongoing Phase 1/2a Trial (NCT05150691)

ESGO eAcademy, Kathleen Moore, 403660

Can Tumour Biology Guide Surgical Strategies? Part 3: The Interacting Roles of Pattern and Extent of Disease and “Patient’s Biology”

ESGO eAcademy, Giovanni Aletti, 403650

A Signature Of Genes Related To Obesity And Lipid Metabolism And Expressed In The Primary Tumor Better Predicts Long-Term Prognosis Than Body Mass Index In Endometrial Cancer.

ESGO eAcademy, Mauricio Cuello, 403659

If Checkpoint Inhibitors Fail: What Can We Do?

ESGO eAcademy, Angelica Rodrigues, 403653

Diagnostic Potential Of DNA Methylation Detection For Endometrial Cancer In Reproductive-Aged Women Presenting With Abnormal Uterine Bleeding

ESGO eAcademy, Xingping Zhao, 403658

Can Tumour Biology Guide Surgical Strategies? Part 2: The Role Molecular Biology and Genetics

ESGO eAcademy, Elena Ioanna Braicu, 403649

The Relationship Between Mismatch Repair Deficiency And Lymphovascular Space Invasion In Endometrial Cancer

ESGO eAcademy, Merve Aldikactioglu Talmac, 403657

Is Immunotherapy Beating Recurrent/Metastatic Cervical Cancer?

ESGO eAcademy, Ana Oaknin, 403652

Safety Of Dostarlimab In Combination With Chemotherapy In Patients With Primary Advanced Or Recurrent Endometrial Cancer In A Phase 3, Randomized, Placebo-Controlled Trial (ENGOT-EN6-NSGO/GOG-3031/RUBY)

ESGO eAcademy, Annika Auranen, 403656

The Impact Of Molecular Classes On Oncologic Outcome Of Endometrial Cancer: A Prospective Analysis From A Tertiary Referral Center.

ESGO eAcademy, Livia Xhindoli, 403655

Tackling Locally Advanced Cervical Cancer: Past, Present And Future?

ESGO eAcademy, Bradley J. Monk, 403651

Can Tumour Biology Guide Surgical Strategies? Part 1: The Role Of Histological Type

ESGO eAcademy, Andreas du Bois, 403648

IJGC Awards

ESGO eAcademy, Pedro Ramirez, 403647

ESGO Professional Certification Awards

ESGO eAcademy, Maja Pakiz, 403646

Discussant

ESGO eAcademy, Antonio Gonzalez Martin, 403644

Integrated Multi-Omic And Clinicopathological Analysis Of High-Grade Serous Ovarian Cancer In BRCA1/2 Mutated Patients With Poor Survival: Identification Of Predictive Biomarkers For Personalized Treatment

ESGO eAcademy, Tibor Zwimpfer, 403643

MIRASOL Trial: Efficacy Of Mirvetuximab Soravtansine In Folate Receptor Alpha High, Platinum Resistant Ovarian Cancer By Type And Number Of Prior Treatment Regimes: An Exploratory Analysis.

ESGO eAcademy, Toon Van Gorp, 403642

Durvalumab With Paclitaxel/Carboplatin + Bevacizumab Then Maintenance Durvalumab, Bevacizumab + Olaparib In Patients With Newly Diagnosed Advanced Ovarian Cancer Without A Tumour BRCA1/2 Mutation: Results From The DUO-O/ENGOT-Ov46/AGO-OVAR 23/GOG-3025 Trial

ESGO eAcademy, Christian Marth, 403641

Discussant

ESGO eAcademy, Pedro Ramirez, 403640

Hyperthermic Intraperitoneal Chemotherapy In Platinum-Sensitive Relapsed Epithelial Ovarian Cancer: The CHIPOR Randomised Phase III Trial.

ESGO eAcademy, Pierre Meeus, 403639

SHAPE Trial: An International Randomized Phase III Trial Comparing Radical Hysterectomy And Pelvic Node Dissection (RH) Vs Simple Hysterectomy And Pelvic Node Dissection (SH) In Patients With Low-Risk Early-Stage Cervical Cancer (LRESCC)

ESGO eAcademy, Marie Plante, 403638

A Clinical Case: Toxicity Management

ESGO eAcademy, Nicoletta Colombo, 403637

A Clinical Case: New Treatment Algorithm

ESGO eAcademy, Bradley J. Monk, 403636

Endometrial Cancer: A Paradigm Shift

ESGO eAcademy, Domenica Lorusso, 403635

1.1.1 Anatomy of pelvis and abdomen

ESGO eAcademy, Faculty / Presenters, 404250

1.1.2 Staging cancers

ESGO eAcademy, Faculty / Presenters, 404251

1.2.1 HPV cancerogenesis and vaccination

ESGO eAcademy, Faculty / Presenters, 404253

1.2.2 Basic principles of cancer immunology

ESGO eAcademy, Faculty / Presenters, 404254

1.3.1 Clinical genetics in gynecologic cancers

ESGO eAcademy, Faculty / Presenters, 404255

1.4.1 Screening for gynecological cancers

ESGO eAcademy, Faculty / Presenters, 404257

1.4.3 Ultrasound in gynecologic oncology

ESGO eAcademy, Faculty / Presenters, 404259

1.5.1 Principles of surgical approach in gynecologic oncology

ESGO eAcademy, Faculty / Presenters, 404261

1.5.3 Radical hysterectomy and pelvic exenteration

ESGO eAcademy, Faculty / Presenters, 404263

1.5.6 Principles Vulvar cancer surgery, surgical techniques in vulvar cancers

ESGO eAcademy, Faculty / Presenters, 404266

1.6.1 Gastrointestinal and liver surgery in gynecologic oncology

ESGO eAcademy, Faculty / Presenters, 404268

1.6.2 Urinary diversion after pelvic exenteration for gynecologic malignancies

ESGO eAcademy, Faculty / Presenters, 404269

1.6.3 Plastic surgery in gynecologic oncology

ESGO eAcademy, Faculty / Presenters, 404270

1.7.1 Perioperative care in gynecologic oncology

ESGO eAcademy, Faculty / Presenters, 404271

1.8.1 Basics of pharmacology

ESGO eAcademy, Faculty / Presenters, 404272

1.8.3 Complications of systemic treatment

ESGO eAcademy, Faculty / Presenters, 404274

1.9.1 Basic principles of external beam radiation therapy

ESGO eAcademy, Faculty / Presenters, 404275

1.9.2 Basic principles of brachytherapy

ESGO eAcademy, Faculty / Presenters, 404276

1.9.3 Complications of radiotherapy, adverse events, prevention and treatment

ESGO eAcademy, Faculty / Presenters, 404277

1.10.1 Follow up in gynecologic oncology

ESGO eAcademy, Faculty / Presenters, 404278

1.11.1 Palliative care

ESGO eAcademy, Faculty / Presenters, 404279

1.11.2 Basic psychology in gynecologic oncology

ESGO eAcademy, Faculty / Presenters, 404280

1.11.3 End of life care and assisted dying

ESGO eAcademy, Faculty / Presenters, 404281

1.12.1 Communication: How to learn and to deliver breaking bad news in gynaecological oncology

ESGO eAcademy, Faculty / Presenters, 404282

1.12.1 Communication with colleagues and clinical audit

ESGO eAcademy, Faculty / Presenters, 404283

1.12.3 Measuring of oncological care

ESGO eAcademy, Faculty / Presenters, 404284

1.13.1 General principles in medical research

ESGO eAcademy, Faculty / Presenters, 404285

1.13.2 Statistics for prospective clinical trials

ESGO eAcademy, Faculty / Presenters, 404286

1.13.3 Scientific writing and peer-review process

ESGO eAcademy, Faculty / Presenters, 404287

2.1.1 Pathology of ovarian cancer

ESGO eAcademy, Faculty / Presenters, 404288

2.1.2 Clinical management of high-grade epithelial ovarian cancer

ESGO eAcademy, Faculty / Presenters, 404289

2.1.3 Clinical management of borderline and low-grade epithelial tumours of the ovary

ESGO eAcademy, Faculty / Presenters, 404290

2.1.4 Non epithelial ovarian cancer

ESGO eAcademy, Faculty / Presenters, 404291

2.2.1 Pathology of the uterus

ESGO eAcademy, Faculty / Presenters, 404292

2.2.2 Clinical management of epithelial uterine tumours

ESGO eAcademy, Faculty / Presenters, 404293

2.2.3 Clinical management of mesenchymal uterine tumours: Principles of surgery, systemic treatment

ESGO eAcademy, Faculty / Presenters, 404294

2.3.1 Pathology of cervical malignant tumours

ESGO eAcademy, Faculty / Presenters, 404295

2.3.2 Clinical management of cervical malignant tumours

ESGO eAcademy, Faculty / Presenters, 404296

2.4.1 Vaginal cancer

ESGO eAcademy, Faculty / Presenters, 404297

2.5.1 Overview of vulvar cancer

ESGO eAcademy, Faculty / Presenters, 404298

2.6.1 Gestational trophoblastic disease

ESGO eAcademy, Faculty / Presenters, 404299

2.7.1 Fertility sparing aproach: Definition, When is feasible, Fertility sparing management in each cancer

ESGO eAcademy, Faculty / Presenters, 404300

2.7.2 Basics of reproductive medicine

ESGO eAcademy, Faculty / Presenters, 404301

2.8.1 Cancer and pregnancy

ESGO eAcademy, Faculty / Presenters, 404302